Abstract
Background Evidence supports cortical reorganization in sensorimotor areas induced by constraint-induced movement therapy (CIMT). However, only a few studies examined the neural plastic changes as a function of task specificity. This provoked us to retrospectively analyze a previously unpublished imaging dataset from chronic stroke survivors before and after participation in the signature CIMT protocol. This exploratory analysis aims to evaluate the functional brain activation changes during a precision and a power grasp task in chronic stroke survivors who received two-weeks of CIMT compared to a control group.
Materials and methods Fourteen chronic stroke survivors, randomized to CIMT (n=8) or non-CIMT (n=6), underwent functional MRI (fMRI) before and after a two-week period. During scan runs, participants performed two different grasp tasks (precision, power). Pre to post changes in laterality index (LI) were compared by group and task for two predetermined motor regions of interest: dorsal premotor cortex (PMd) and primary motor cortex (MI).
Results Two weeks of CIMT resulted in a relative increase in activity in a key region of the motor network, the PMd of the lesioned hemisphere, under precision grasp task conditions compared to a non-treatment control group. However, no changes in LI were observed in MI for either task or group.
Conclusion These findings provide evidence for the task specificity effects of CIMT in the promotion of recovery-supportive cortical reorganization in chronic stroke survivors.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04989920
Funding Statement
The study was supported by National Institutes of Health grants NS 45485 to Dr. Carolee Winstein, R24 HD 39629 (Western Medical Rehabilitation Research Network) to Dr. Bruce Dobkin and F31HD098796 to Dr. Rini Varghese. The study was also supported by the post-doctoral fellowship from the Fonds de la Recherche du Quebec Sante (#268272) to Dr. Marika Demers. The study was supported by funding from the Ahmanson-Lovelace Brain Mapping Center, the National Center for Research Resources grants RR12169, RR13642, and RR08655 NIH NIDA K12DA000167 and American Heart Association 14CRP18200010. The funding sources did not have a role in the redaction of this manuscript.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
University of Southern California (USC) Health Sciences Campus IRB, HS-016022.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.